Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
The single-cell pathology landscape of breast cancer.
Nature
; 578(7796): 615-620, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959985
3.
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.
Nature
; 567(7748): 399-404, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867590
4.
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
Mod Pathol
; 32(9): 1244-1256, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30976105
5.
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Int J Cancer
; 143(4): 746-757, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492969
6.
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
Nature
; 481(7381): 389-93, 2012 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22217937
7.
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.
BMC Cancer
; 17(1): 657, 2017 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931370
8.
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res
; 18(1): 21, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882907
9.
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Breast Cancer Res
; 18(1): 104, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756439
10.
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.
PLoS Med
; 13(12): e1002194, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959923
11.
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.
Br J Cancer
; 114(3): 298-304, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679376
12.
Spatial Biology of Breast Cancer.
Cold Spring Harb Perspect Med
; 14(5)2024 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110242
13.
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
J Pathol
; 227(3): 306-14, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294324
14.
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.
J Pathol
; 226(1): 97-107, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953021
15.
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
Eur J Cancer
; 195: 113379, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913680
16.
Breast tumor microenvironment structures are associated with genomic features and clinical outcome.
Nat Genet
; 54(5): 660-669, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437329
17.
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.
Breast Cancer Res
; 13(6): R118, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22112299
18.
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response.
Nat Commun
; 12(1): 1998, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790302
19.
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation.
Nat Commun
; 12(1): 5406, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518533
20.
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer.
Nat Cancer
; 1(2): 163-175, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122013